34
Participants
Start Date
June 30, 2016
Primary Completion Date
October 31, 2019
Study Completion Date
October 31, 2019
Regorafenib
3 tablets once a day by mouth for 21 consecutive days of 28 day cycle for 26 cycles
Placebo
3 tablets once a day by mouth for 21 consecutive days of 28 day cycle for 26 cycles
Allegheny General Hospital, Pittsburgh
UPMC Cancer Centers, Pittsburgh
Scranton Hematology Oncology, Scranton
Guthrie Medical Group, PC, Sayre
Abington Hospital -Jefferson South, Abington
Thomas Jefferson University Hospital, Philadelphia
Reading Hospital - McGlinn Cancer Institute, West Reading
Virginia Commonwealth University, Richmond
West Virginia University, Morgantown
Wake Forest Baptist Health, Winston-Salem
Waverly Hematology Oncology, Cary
CaroMont Regional Medical Center, Gastonia
First Health of the Carolinas Cancer Center, Pinehurst
Margaret R. Pardee Memorial Hospital, Hendersonville
McLeod Cancer Center for Treatment and Research, Florence
AnMed Health Cancer Center, Anderson
Memorial Health University Medical Center, Savannah
University of Florida, Gainesville
Mount Sinai Comprehensive Cancer Center, Miami Beach
Wellmont Medical Associates Oncology and Hematology, Kingsport
Thompson Cancer Survival Center, Knoxville
Norton Cancer Institute, Norton Healthcare Pavilion, Louisville
James Cancer Hospital and Solove Research Institute at the Ohio State University Comprehensive Cancer Center, Columbus
Toledo Clinic Cancer Center, Toledo
Northern Indiana Cancer Research Consortium, South Bend
Breslin Cancer Center, Lansing
Covenant Cancer Treatment Center, Waterloo
University of Iowa, Iowa City
Oncology Associates at Mercy Medical Center, Cedar Rapids
Genesis Medical Center - West Campus, Davenport
Green Bay Oncology, Ltd. - St. Vincent Hospital, Green Bay
Metro Minnesota Community Oncology Research Consortium, Saint Louis Park
Carle Cancer Center, Urbana
Cancer Care Specialists of Illinois - Decatur Memorial Hospital, Decatur
Missouri Valley Cancer Consortium, Omaha
Tulane University Health Sciences Center, New Orleans
Joe Arrington Cancer Research and Treatment Center, Lubbock
Colorado Cancer Research Program, Denver
Nevada Cancer Research Foundation, Inc., Las Vegas
St. Joseph Hospital of Orange, Orange
Kaiser Permanente Medical Center - Vallejo, Vallejo
St. Joseph Heritage Healthcare, Santa Rosa
Yale University, New Haven
Edward Hospital Cancer Center, Naperville
New England Cancer Specialists, Scarborough
Berkshire Medical Center Cancer and Infusion Center, Pittsfield
MD Anderson Cancer Center at Cooper, Camden
Monmouth Medical Center, Long Branch
Newark Beth Israel Medical Center, Newark
Community Medical Center, Toms River
Penn State Cancer Institute at Milton S. Hershey Medical Center, Hershey
Collaborators (1)
Bayer
INDUSTRY
NSABP Foundation Inc
NETWORK